[PDF] Top 20 On the use of agents in a bioInformatics grid
Has 10000 "On the use of agents in a bioInformatics grid" found on our website. Below are the top 20 most common "On the use of agents in a bioInformatics grid".
On the use of agents in a bioInformatics grid
... data-intensive bioinformatics and the provision of a distributed environment that supports the in silico experi- mental ...the Grid becomes egocentrically based around the Scientist: ... See full document
8
Does the use of targeted agents in advanced gastroesophageal cancer increase complete response? A meta-analysis of 18 randomized controlled trials
... Although the CR is a rate event in advanced GEC patients, adding the TAs to therapies, especially for anti-EGFR agents, increases the chance of archiving CR in comparison with the controls. Further studies are ... See full document
10
Update on the use of systemic biologic agents in the treatment of noninfectious uveitis
... immunosuppressive agents (such as methotrexate, azathioprine, mycophenolate mofetil, and cyclosporine) may not be sufficient to control ocular inflammation or prevent non-ophthalmic complications in refractory ... See full document
15
On the Use of Agents in a BioInformatics Grid
... The approa h may be summarised as follows: implementors of a servi e have to implement an interfa e for he kpoint and rollba k; the ar hite ture dynami ally extends the servi e interfa e[r] ... See full document
14
An update on the use of Atripla<sup>®</sup> in the treatment of HIV in the United States
... Since its arrival in the United States market, Atripla has steadily become the initial regimen of choice for antiretroviral naive patients initiating CART. Over 30% of all HIV-infected patients on antiretroviral therapy ... See full document
6
Agents in Bioinformatics
... Andreas Doms started his talk from the following consideration: in biology data grows superlin- early. Nowadays, DNA sequences in the human genome are equal to 3.2 Gbp (equivalent in size to 6 complete years of the New ... See full document
9
Agents and the Grid: Service Discovery
... years, bioinformatics has undergone a rapid and substantial ...the bioinformatics domain should be able to cope with this dynamism and openness, and nothing addresses these concerns as comprehensively as ... See full document
22
Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants
... reversal agents (both specific antidotes and nonspecific reversal agents, such as PCC) to guide clinical decisions on whether to administer subsequent ...the use of specific ... See full document
11
The use of capecitabine in daily practice: a study on adherence and patients' experiences
... Background: Adherence to pharmacological therapy is a complex and multifactorial issue that can substantially alter the outcome of treatment. Especially when using long-term medica- tion, cancer patients have adherence ... See full document
8
Automating Experiments Using Semantic Data on a Bioinformatics Grid
... the Grid), het- erogeneous services provide similar capa- bilities but with varying ...can use them in the same ...pean Bioinformatics Institute as part of the myGrid ... See full document
8
Social grid agents
... Fair-share scheduling [35, 42] entails that all users belonging to the VOs encom- passed in a Grid can receive the services that were agreed upon when they joined the Grid. Although simple in principle this ... See full document
250
Applying agents to bioinformatics in GeneWeaver
... of agents and shows how they ...calculation agents (in- cluding the Blast Agent and the Clustal Agent that perform specific analysis tasks) attempt to annotate sequences in the database using relevant ... See full document
13
Update on the optimal use of bortezomib in the treatment of multiple myeloma
... Based on these early results, it seems unlikely that bort- ezomib will be replaced by either carfilzomib or ixazomib, rather the PIs will remain a backbone of myeloma therapy and the most appropriate PI will be chosen ... See full document
13
Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy
... their use on account of potential systemic absorption, or those who demonstrate dissatisfac- tion in terms of efficacy and safety, it is clear that there is a significant unmet medical need in VVA ... See full document
10
A Study on the Use of Conjunction by American Chinese Learners based on HSK Corpus
... By analyzing the Chinese compositions written by American Chinese learners in HSK corpus, this paper finds that American learners tend to use conjunctions in Chinese writing. The most frequently used conjunctions ... See full document
9
The use of lorcaserin in the management of obesity: a critical appraisal
... The mean body weight among patients who received lorcaserin both years was lowest compared with patients who received placebo in both years or patients receiving lorcaserin in year 1 [r] ... See full document
7
The Role of the Dumai City Government in the Use of Reducing Poverty
... Volume 3, Issue 10, October – 2018 International Journal of Innovative Science and Research Technology ISSN No 2456 2165 IJISRT18OC388 www ijisrt com 519 The Role of the Dumai City Government in the U[.] ... See full document
12
Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis
... Although the etiological and pathophysiological mechanisms of AMD are not yet elucidated, an extensive abnormal ocular neovascularization has been recognized as the main reas[r] ... See full document
12
An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations
... clinical outcomes for existing disease states are major areas of interest for the journal. This journal has been accepted for indexing on PubMed Central. The manuscript management system is completely online and includes ... See full document
10
The Influence of Airflow Characteristics and Accumulation Grid Velocity on the Formation of a Stone Wool Primary Layer
... Fig. 2 shows the final primary layer structure when it exits the collecting chamber. On the top and bottom of the image, nonilluminated (lower green rectangular) and illuminated (upper blue rectangular) areas are marked. ... See full document
10
Related subjects